Jo-Anne H Young

F2G LTD

1/19/23 → 1/31/28

Project: Research project

A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added to systemic antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis

PULMOCIDE, LTD

9/22/22 → 9/30/27

Project: Research project

A Phase3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or InvasiveCandidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Intravenous Echinocandin followed by OralFluconazole

SCYNEXIS, INC.

7/14/22 → 7/31/27

Project: Research project

Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)

3/23/22 → 6/30/28

Project: Research project

Phase 2 multicenter, randomized, double-blind, placebo-controlled, multiple dosing interval, 3-period studyof the safety, tolerability and effectiveness of adoptively transferred Viralym-M multivirus-specific T cells inkidney transplant recipients w

4/28/21 → 11/30/25

Project: Research project

An Open-label, Single-arm Study of Letermovir (LTV) for Prevention of Recurrent CMV Infection in HighriskHematopoietic Cell Transplant (HCT) Recipients

MEMORIAL SLOAN-KETTERING CANCER CENTER, MERCK, SHARP & DOHME LLC

11/15/20 → 11/30/25

Project: Research project

Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M(ALVR-105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After AllogeneicHematopoietic Cell Transplant

11/15/20 → 11/30/25

Project: Research project

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety andEfficacy of Viralym-M Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCVInfection and/or Disease, in High-Risk Patients After Al

10/1/20 → 10/31/25

Project: Research project

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY, TOLERABILITY, AND EFFICACY OF RV521 IN THE TREATMENT OF ADULT SUBJECTS WHO HAVE UNDERGONE HEMATOPOIETIC CELL TRANSPLANTATION (HCT) WITH A DOCUMENTED UPPER RESPIRATORY TRACTINFECTION (URT)

REVIRAL LTD

6/24/20 → 1/31/24

Project: Research project

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney TransplantRecipients at High-Risk of Cytomegalovirus Infection, LionHeart21

NOBELPHARMA CO., LTD

6/12/20 → 6/30/25

Project: Research project

A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium(Clostridioides) Difficile Infection

VEDANTA BIOSCIENCES, INC

8/22/19 → 8/30/24

Project: Research project

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Tran

JANSSEN RESEARCH & DEVELOPMENT, LLC

7/31/19 → 7/31/24

Project: Research project

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Combination Therapy of SCY-078 with Voriconazole in Patients with Invasive Pulmonary Aspergillosis (SCYNERGIA)

SCYNEXIS, INC.

3/29/19 → 3/30/24

Project: Research project

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for theTreatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

ANSUN BIOPHARMA, INC

2/6/19 → 2/29/24

Project: Research project

A Multi-center, Retrospective Study of Serious Infections Caused by Acinetobacter baumanniicalcoaceticusComplex

ENTASIS THERAPEUTICS HOLDINGS INC

11/25/18 → 11/30/23

Project: Research project

Open-Label Study to Evaluate the Efficacy and Safety of

SCYNEXIS, INC.

11/1/16 → 6/30/24

Project: Research project

A Prospective Observational Study for the Long-term

11/5/14 → 11/4/24

Project: Research project

Finished

A multi-site randomized trial of subject-collected CMV driedblood spot testing with mobile technology support to optimizepreemptive therapy late after allogeneic HCT

FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)

2/16/22 → 8/15/23

Project: Research project

Targeted Clinical Research to Address Select Viral Infections

FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)

6/16/20 → 6/15/23

Project: Research project

Clinical Performance of the Aptima CMV Quant Assay on the Panther System

HOLOGIC, INC

3/13/19 → 10/25/19

Project: Research project

SUBA-itraconazole versus conventional itraconazole in the treatment of endemic mycoses; a multi-center,open-label, randomized comparative trial

THE UNIVERSITY OF ALABAMA AT BIRMINGHAM, MAYNE PHARMA INTERNATIONAL

2/14/19 → 2/28/23

Project: Research project

Advisory Board Consulting Agreement

JANSSEN GLOBAL SERVICES, LLC

1/11/19 → 2/27/19

Project: Research project

A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy andSafety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, ElderlyHospitalized Patients With Influenza A Infection

JANSSEN RESEARCH & DEVELOPMENT, LLC, U.S. DEPARTMENT OF HEALTH & HUMAN SVCS

10/1/18 → 10/30/21

Project: Research project

A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety ofRezafungin for Injection vs Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down inthe Treatment of Subjects with Candidemia and/or In

CIDARA THERAPEUTICS, INC.

8/1/18 → 12/31/22

Project: Research project

Endpoint Adjudication Committee (EAC) for the study

NOHLA THERAPEUTICS, INC

2/21/18 → 2/20/21

Project: Research project

VL2397-201: A Phase 2 Study of VL-2397 Compared to Stand

VICAL INCORPORATED

12/1/17 → 12/31/20

Project: Research project

Targeted Clinical Research to Address Select Viral Infections

FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)

11/8/17 → 12/31/21

Project: Research project

A Phase 3, Multicenter, Randomized, Open-label, Active-c

SHIRE HUMAN GENETIC THERAPIES, INC.

1/1/17 → 4/30/21

Project: Research project

Survey of Bloodstream Infections in High Risk Neutropeni

UNIVERSITY OF NEBRASKA MEDICAL CENTER, MERCK

11/15/16 → 1/31/20

Project: Research project

A Non-Interventional Registry Study of Systemic Antifung

ASTELLAS PHARMA, INC

9/1/16 → 6/30/22

Project: Research project

Observational Disease Registry of Patients Treated with

ASTELLAS PHARMA, INC

9/1/16 → 6/30/22

Project: Research project

A Phase 3, Multicenter, Randomized, Double-blind, Double

SHIRE HUMAN GENETIC THERAPIES, INC.

8/1/16 → 12/31/22

Project: Research project

A Randomized, Open-Label, Multicenter Study of Liposomal

INSMED INC

8/1/16 → 11/1/16

Project: Research project

A Phase 2b, Randomized, Double-blind, Single-dose

MEDIMMUNE, LLC

7/1/16 → 12/31/17

Project: Research project

A Phase 2b, Randomized, Controlled Trial Evaluating GS-5

GILEAD SCIENCES, INC.

7/14/15 → 12/31/17

Project: Research project

A Multicenter Non-Interventional Study to Obtain Retrosp

1/20/15 → 12/31/17

Project: Research project

A Phase II, Randomized, Double-Blind, Active-Controlled

SUMMIT PLC

6/17/14 → 12/31/15

Project: Research project

A Phase III Randomized, Placebo-Controlled Clinical Tria

MERCK AND CO INC

6/11/14 → 12/31/17

Project: Research project

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled

GILEAD SCIENCES, INC.

6/10/14 → 12/31/17

Project: Research project

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled

GILEAD SCIENCES, INC.

6/10/14 → 4/30/18

Project: Research project

A Phase 3, Open-Label, Multicenter Study of the Safety

3/15/14 → 4/30/18

Project: Research project

HZ vaccine in adults with haematologic malignancies- Zos

GLAXOSMITHKLINE

1/1/14 → 3/31/18

Project: Research project

Natural History of Infection Caused by BK Virus (and oth

THE UNIVERSITY OF ALABAMA AT BIRMINGHAM, NATIONAL INSTITUTES OF HEALTH (NIH)

9/28/13 → 12/31/19

Project: Research project

GSK HZ gE/AS01B vaccine in HCT recipients- Zoster 002

CUBIST PHARMACEUTICALS, INC

GLAXOSMITHKLINE

7/1/12 → 12/31/20

Project: Research project

A Randomized, Double-Blinded, Active-Controlled Study of

Green, J. S. & Young, J. H.

7/1/12 → 6/30/14

Project: Research project

A Randomized, Placebo-Controlled, Multi-Site Phase 2 Stu

10/31/11 → 12/31/13

Project: Research project

A Phase III, Double-Blind, Randomized Study to Evaluate

ASTELLAS PHARMA US, INC

7/20/11 → 12/31/14

Project: Research project

A Phase III, Double Blind, Randomized Study to Evaluate

ASTELLAS PHARMA US, INC

6/13/11 → 12/31/14

Project: Research project

Open Label Study of Isavuconazole in the Treatment

ASTELLAS PHARMA US, INC

6/1/11 → 12/31/14

Project: Research project

Pharmacokinetics, Safety, and Tolerability of Intravenou